肝着（慢性乙型肝炎）临床路径实施效果分析中医内科学专业论文.docxVIP

PAGE PAGE 10 中 文 摘 要 目 的: 通过对慢性乙型肝炎临床路径实施情况的分析，评价临床路径 应用于临床的效果。方法: 选择我院 60 例符合诊断标准的慢性乙型肝炎 轻中度患者，随机分为治疗组 30 例与对照组 30 例，治疗组采取临床路 径管理方案，对照组采取传统临床管理方案，比较 2 组患者在住院时间、 医疗费用及患者满意度方面的差异。 结 果: 观察组患者的平均门诊天数为 27 d，次均治疗总费用为 4236.8±1523.6 元，对照组患者的平均住院时间为 30 d，次均治疗总费 用为 5178.2±1954.3 元。治疗组临床痊愈率为 85.00%，好转率 15.00%, 无效率 0%,恶化率 0%,死亡率 0%。与非路径组相比，患者治疗天数由 32 天降低为 27 天（P 0.05）。其中肝功能复常平均所需时间由 28 天降为 22 天，主要症状改善平均所需时间由 25 天降为 20 天，对每个患者出院 后均进行满意度调查，分类总结并量化后，对临床路径组和非路径组进 行比较检验。结果表明，临床路径组效果满意度 98%、对医务人员满意度 100%、对治疗时间的满意率为 96%，这三个方面明显高于非路径组（90%； 95%；90%）。 结 论: 采用临床路径管理慢性乙型肝炎患者能显著缩短治疗时间，减 少医疗费用。 关键词：肝着；慢性乙型肝炎；治疗；费用；临床路径 The clinical pathway implementation effect analysis of The liver (chronic hepatitis b) Abstract Objective: the clinical pathway for chronichepatitisb on the implemen- tation of the analysis, evaluation of clinical pathway applied to clinical effect. Methods: choose 60 patients with our criteria for the diagnosis of chro- nic hepatitis b patients with mild-to-moderate, divided into the treatment gro- up and control group 30 cases 30 cases, the treatment group to take a clinical pathway management plan, the control group adopts the traditional clini cal management solutions, contrast 2 groups of patients in hospital stay, medical expenses, health knowledge and master the differences of the patient satisfac- tion. Results: the observation group of patients with average outpatient serv- ice Numbers as 27 d, second all treatment total cost is 4236.8±1523.6 yuan, patients the mean hospital stay was 30 d, second all treatment total cost is 5178.2±1954.3 yuan. The treatment group clinical cure rate was 85.00%, the recovery 15.00%, not 0% efficiency, deterioration rate by 0%, the death rate of 0%. Compared with the path group, were treated by 32 days days reduced to 27 days (P 0.05). Liver function of complex time needed for an average often by 28 heaven for 22 days, the main symptoms improve time needed for an average of 25 heaven for 20 days, for each patient after hospita